Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Drug Combinations × Clear all

NCT03977272 2023-01-27

Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms